Sonnet BioTherapeutics Faces Delisting Concerns
| Field | Detail |
|---|---|
| Company | Sonnet Biotherapeutics Holdings, Inc. |
| Form Type | 8-K |
| Filed Date | Jun 2, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-standards, regulatory
TL;DR
Sonnet BioTherapeutics might get delisted, big trouble for the stock.
AI Summary
Sonnet BioTherapeutics Holdings, Inc. filed an 8-K on May 30, 2025, to report a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as Chanticleer Holdings, Inc., is incorporated in Delaware and has its principal business address in Princeton, New Jersey.
Why It Matters
This filing indicates potential issues with Sonnet BioTherapeutics' continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's ability to remain publicly traded.
Key Players & Entities
- Sonnet BioTherapeutics Holdings, Inc. (company) — Registrant
- Chanticleer Holdings, Inc. (company) — Former company name
- May 30, 2025 (date) — Date of earliest event reported
- Princeton, New Jersey (location) — Principal business address
FAQ
What specific listing rule or standard has Sonnet BioTherapeutics Holdings, Inc. failed to satisfy?
The filing does not specify the exact rule or standard that has not been met, only that a notice has been issued.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is May 30, 2025.
What were Sonnet BioTherapeutics Holdings, Inc.'s former names?
The company was formerly known as Chanticleer Holdings, Inc. and TULVINE SYSTEMS INC.
In which state is Sonnet BioTherapeutics Holdings, Inc. incorporated?
The company is incorporated in Delaware.
What is the primary business address of Sonnet BioTherapeutics Holdings, Inc.?
The principal business address is 100 Overlook Center, Suite 102, Princeton, New Jersey 08540.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 2, 2025 regarding Sonnet BioTherapeutics Holdings, Inc..